Together, our study firstly disclosed a novel circRNA0005276 as a potential therapeutic marker in PCa by revealing that circ0005276/FUS promoted the tumorigenesis and development of PCa through regulating XIAP expression. The gene discussed is XIAP; the disease is posterior cortical atrophy.